(Q51673689)

9 April 2018

reason for preferred rank

title

Composite Spirometric–Computed Tomography Outcome Measure in Early Cystic Fibrosis Lung Disease (English)

1 reference

https://api.crossref.org/works/10.1164/RCCM.200209-1093OC

2 January 2024

Composite spirometric-computed tomography outcome measure in early cystic fibrosis lung disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12746252

health care outcome assessment

2 January 2024

main subject

cystic fibrosis

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12746252

2 January 2024

2

Ann N. Leung

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12746252

2 January 2024

8

Richard B. Moss

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12746252

2 January 2024

author name string

Terry E. Robinson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12746252

2 January 2024

William H. Northway

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12746252

2 January 2024

Francis G. Blankenberg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12746252

2 January 2024

Frandics P. Chan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12746252

2 January 2024

Daniel A. Bloch

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12746252

2 January 2024

Tyson H. Holmes

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12746252

2 January 2024

language of work or name

English

0 references

publication date

13 May 2003

1 reference

9 April 2018

full work available at URL

https://www.atsjournals.org/doi/pdf/10.1164/rccm.200209-1093OC

1 reference

https://api.crossref.org/works/10.1164/RCCM.200209-1093OC

American Journal of Respiratory and Critical Care Medicine

2 January 2024

published in

1 reference

9 April 2018

volume

168

1 reference

9 April 2018

page(s)

588-593

1 reference

9 April 2018

issue

5

1 reference

9 April 2018

Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1093OC

Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1093OC

A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1093OC

Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1093OC

Current understanding of the inflammatory process in cystic fibrosis: onset and etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1093OC

Use of computerized tomography and chest x-rays in evaluating efficacy of aerosolized recombinant human DNase in cystic fibrosis patients younger than age 5 years: a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1093OC

Serum and lower respiratory tract drug concentrations after tobramycin inhalation in young children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1093OC

Effect of choice of reference equation on analysis of pulmonary function in cystic fibrosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1093OC

Spirometer-triggered high-resolution computed tomography and pulmonary function measurements during an acute exacerbation in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1093OC

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1093OC

Estimating effectiveness in an observational study: a case study of dornase alfa in cystic fibrosis. The Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1093OC

Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1093OC

Pulmonary function between 6 and 18 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1093OC

An automated approach to quantitative air trapping measurements in mild cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1093OC

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1093OC

Identifying treatments that halt progression of pulmonary disease in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1093OC

Lungs in infants and young children: improved thin-section CT with a noninvasive controlled-ventilation technique--initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1093OC

High-resolution computed tomography of the chest in children with cystic fibrosis: support for use as an outcome surrogate

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1093OC

Application of chest high-resolution computer tomography in young children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1093OC

Technique and clinical applications of full-inflation and end-exhalation controlled-ventilation chest CT in infants and young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1093OC

High-resolution CT in the acute exacerbation of cystic fibrosis: evaluation of acute findings, reversibility of those findings, and clinical correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1093OC

Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1093OC

Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1093OC

Standardized high-resolution CT of the lung using a spirometer-triggered electron beam CT scanner

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1093OC

Early pulmonary inflammation in infants with cystic fibrosis

21 January 2018

8

1 reference

https://api.crossref.org/works/10.1164/RCCM.200209-1093OC

Pediatric pulmonary disease: assessment with high-resolution ultrafast CT.

2 January 2024

10

1 reference

https://api.crossref.org/works/10.1164/RCCM.200209-1093OC

Cystic fibrosis: CT assessment of lung involvement in children and adults

2 January 2024

12

1 reference

https://api.crossref.org/works/10.1164/RCCM.200209-1093OC

2 January 2024

Identifiers

1 reference

9 April 2018

1 reference

9 April 2018